Skip to main content
Amy Landucci

Amy Landucci

We know that technology touches every part of our lives, and everyday health is no exception. At Haleon, we are leveraging data, technology and insights to develop products and services that meet the needs of our consumers and customers around the world.”

— Amy Landucci

Amy is Haleon’s Chief Digital and Technology Officer, a role she’s held since 2021, while the business was still part of GSK.

Prior to joining GSK in 2017, as Chief Information Officer for Consumer Healthcare, Amy spent more than a decade at Novartis, where she was most recently the Global Head of Digital Medicines. She was responsible for defining and delivering the "beyond the pill" strategy and solutions to accelerate Novartis's entrance into Digital Medicines. Prior to this role, Amy was Chief Information Officer for the Novartis OTC Division.

Amy previously served on the Board of Directors for Healthy Women, the leading independent, non-profit health information source for women in the US with a mission to educate and empower women to make informed health choices for themselves and their families.

Favourite brand: Chapstick